Get an early start on your networking for South Summit 2024 by checking out our marketplace, where you can find profiles on all the Startups, Corporate Partners, Accelerators and Institutions who will be at the event.
I look for a relationships with a Working on Who can help my project via
Management of neurodegenerative disease is hampered by the lack of objective measures and the infrequency of assessment. We believe “Every patient deserves an objective measurement for when they visit their doctor that is supplemental to the exam." nQ is a computational biotechnology company that captures digital phenotyping through AI-aided analysis of personal device interactions. It has developed digital biomarkers for Parkinson's disease in early and newly diagnosed/untreated stages of disease. In addition to PD, it is currently conducting a number of separate clinical trials to develop digital biomarkers individually relevant to Multiple Sclerosis, ALS, and Alzheimer's. nQ was awarded Breakthrough Status by the FDA in November 2019.
If you have a proposal on some of these areas, we will gladly analyze: